Media Contacts USMedia@galderma.com Zach Randles-Friedman, Head of U.S. Communications: +1 305 299 5700 Filter news by date News Tags - Any -CampaignPress Releases Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Year Year20242023202220212020201920182017201620152014201320122011 Apply 3 . 11 . 2013 Press Releases Epiduo® Tap Program May Increase Patient Adherence To Acne Treatmeat 2 . 12 . 2013 Press Releases Galderma’s Tri-Luma® Cream, Only FDA-Approved Treatment for Melasma, Now Available in Pharmacies 9 . 5 . 2012 Press Releases The Cetaphil® Brand Teams with Camp Wonder 3 . 16 . 2012 Press Releases Galderma Announces Completion Of Phase 3 Trials of Investigational Drug Targeting Facial Erythem of Rosacea 3 . 13 . 2012 Press Releases Cetaphil® Brand Launches Cetaphil® DermaControl™ A New Line of Products for Acne‐Prone Skin 3 . 5 . 2012 Press Releases Galderma Recieves FDA Approval For a New Convenient Pump Dispenser Of Differin® Gel, 0.3% For Treatment Of Acne Vulgaris 2 . 19 . 2012 Press Releases Epiduo® Gel Becomes First Topical Prescription Acne Treatment Available For Children As Young As 9 Years-Old 1 . 17 . 2012 Press Releases Galderma Announces Availability of New Metrogel® 1% Pump Dispenser for the Treatment of Papulopustular Rosacea 12 . 15 . 2011 Press Releases #1 Branded Topical Acne Product, Epiduo® GEL, Recieves FDA Approval For a New Convenient Pump Dispenser Pagination Previous page Previous Page
